Answers are grounded in this paper and cite their sources.
Cross-sectional study examines how gait mechanics influence pain flares in individuals with patellofemoral joint osteoarthritis, suggesting new treatment avenues.
OBJECTIVE: To examine gait mechanics associated with the occurrence of a movement-evoked pain flare in individuals with patellofemoral joint osteoarthritis (PFJOA). DESIGN: Cross-sectional observational study. METHODS: Twenty-two participants with PFJOA and 10 healthy control participants completed five overground gait trials at a fixed speed of 1.35 m/s ± 5%. Lower limb kinematics and kinetics were recorded using motion capture and in-ground force plates. PFJOA participants completed a 20-minute decline treadmill walk, rating pain every minute via the numeric pain rating scale (NPRS). Participants were grouped based on change in NPRS [≥2-point increase = pain flare (PF); <2-point = no flare (NF)]. ANOVA and posthoc analyses compared gait mechanics between groups (PF, NF, and C [control]). RESULTS: During the first half of stance, people with pain flares (n = 12) had higher peak knee flexion angle (17.7 ± 2.4) compared to controls (13.6 ± 3.4; p = .003) and higher knee flexion moment (KFM) impulse (0.62 ± 0.11) compared to people with no pain flare (n = 10) (0.45 ± 0.19; p = 0.001) and to controls (0.39 ± 0.12; p = .0001). The no pain flare group had lower knee adduction moment (KAM) impulse (0.45 ± 0.16) compared to controls (0.61 ± 0.12; p = .04). In the second half of stance, the no pain flare group had higher knee external rotation angles (8.7 ± 5.2) compared to the pain flare group (4.9 ± 3.0; p = 0.02) and to controls (4.5 ± 2.9; p = .009). CONCLUSIONS: People with PFJOA and who were prone to movement-evoked pain flares had increased sagittal plane loading during gait, while those without flares had reduced frontal plane loading and greater knee external rotation angles. Further investigation into a causal relationship between these gait alterations and movement-evoked pain would provide valuable insight for treatment of patients with PFJOA.
No takes yet. Share an insight, caveat, or question.
Wagner et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: